Mineralocorticoid receptor and cardiac a
β
Gravez, Basile; Tarjus, Antoine; Jaisser, Frederic
π
Article
π
2013
π
John Wiley and Sons
π
English
β 242 KB
## Summary βMineralocorticoid receptor (MR) activation has been shown to play a deleterious role in the development of heart disease in studies using specific MR antagonists (spironolactone, eplerenone) in both experimental models and patients. Pharmacological MR blockade attenuates the transition